NGNE

#3177
Neurogene, Inc. Common Stock
24.0000 USD
+15.61%
Sector: Healthcare
Base: USD
Profit Currency: USD
Daily Range
24.0000
24.0000
Year Range
15.9300
35.4700
Daily Change
+15.61%
Monthly Change
+12.04%
6 month change
-18.42%
Year Change
-18.42%
Previous Close
20.7600
Open
24.0000
Bid
Ask
Low
24.0000
High
24.0000
Volume
27
Open full chart

Financials

Overview Statement Statistics
Quarterly Annual
  • Market Capitalization 373.783 M
  • Employee 131
  • Founded 2018
  • CEO Jonathan Drachman M.D.
  • Website www.neurogene.com
  • Headquarter New York, United States
  • FIGI BBG005Y0QDK1
  • Industry Biotechnology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-4.86
Price to sales ratio
—

News